Companies: 10,793     total market cap: A$197.803 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Alnylam Pharmaceuticals
ALNY
#546
Rank
A$62.65 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
A$469.56
Share price
3.38%
Change (1 day)
23.28%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Earnings for Alnylam Pharmaceuticals (ALNY)

Earnings in 2025 (TTM): A$0.86 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's current earnings are A$3.71 Billion. , an increase over its 2024 earnings that were of -A$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alnylam Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 A$0.81 B-344.47%
2024 -A$0.34 Billion-24.59%
2023 -A$0.45 Billion-67.84%
2022 -A$1.37 Billion36.93%
2021 -A$1 Billion-8.04%
2020 -A$1.09 Billion-15.66%
2019 -A$1.29 Billion12.23%
2018 -A$1.15 Billion62.91%
2017 -A$0.71 Billion17.78%
2016 -A$0.6 Billion43.44%
2015 -A$0.42 Billion60.69%
2014 -A$0.26 Billion98.2%
2013 -A$0.14 Billion
2011 -A$77.3 Million27.48%
2010 -A$60.64 Million-10.92%
2009 -A$68.07 Million95.77%
2008 -A$34.77 Million
2006 -A$55.7 Million-9.13%
2005 -A$61.3 Million34.74%
2004 -A$45.5 Million36.79%
2003 -A$33.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.05 B 2,739.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$10.85 B 1,237.20%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
A$7.37 B 808.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$0.36 Billion-143.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-A$66.88 Million-108.24%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-A$0.23 Billion-127.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.03 B 273.75%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
A$0.48 B-40.06%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com